These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26224235)

  • 1. Two cases of successful efavirenz desensitization in patients with several anti-HIV drugs hypersensitivities.
    D'Erme AM; Severino M; Tiradritti L; Testi S; Tchoimou T; Bertelli A; Zuccati G; Gola M
    G Ital Dermatol Venereol; 2015 Aug; 150(4):476-8. PubMed ID: 26224235
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity syndrome associated with efavirenz therapy.
    Bossi P; Colin D; Bricaire F; Caumes E
    Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure.
    Angel-Moreno-Maroto A; Suárez-Castellano L; Hernández-Cabrera M; Pérez-Arellano JL
    J Infect; 2006 Feb; 52(2):e39-40. PubMed ID: 15996743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypersensitivity to efavirenz treated with corticosteroids in a 6-year-old child.
    Foti JL; Piatt JP
    AIDS Patient Care STDS; 2003 Jan; 17(1):1-3. PubMed ID: 12614514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.
    Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; González-García M; Moltó J; Negredo E; Clotet B
    AIDS Rev; 2009; 11(2):103-9. PubMed ID: 19529750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.
    Vitezica ZG; Milpied B; Lonjou C; Borot N; Ledger TN; Lefebvre A; Hovnanian A
    AIDS; 2008 Feb; 22(4):540-1. PubMed ID: 18301070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine sensitivity treated by desensitisation.
    Watts D; Bird J
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):376. PubMed ID: 1829110
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypersensitivity reactions to antiretroviral agents in HIV-infected patients].
    Marcos Bravo MC; Ocampo Hermida A; Moreno Rodilla E
    Med Clin (Barc); 2007 Jan; 128(2):61-9. PubMed ID: 17266904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efavirenz-induced skin eruption and successful desensitization.
    Phillips EJ; Kuriakose B; Knowles SR
    Ann Pharmacother; 2002 Mar; 36(3):430-2. PubMed ID: 11895054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rise and Fall of Efavirenz.
    Cluck D; Lewis P; Durham SH; Hester EK
    J Int Assoc Provid AIDS Care; 2016 May; 15(3):181-3. PubMed ID: 26858315
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypersensitivity reactions to drugs in HIV-infected patients. Allergic evaluation and desensitization.
    Moreno-Ancillo A; López-Serrano MC
    Clin Exp Allergy; 1998 Sep; 28 Suppl 4():57-60. PubMed ID: 9761034
    [No Abstract]   [Full Text] [Related]  

  • 14. Efavirenz-induced exfoliative dermatitis.
    Zhang JC; Sun YT
    Scand J Infect Dis; 2013 Jan; 45(1):70-2. PubMed ID: 22715849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reaction to darunavir and desensitization protocol.
    Marcos Bravo MC; Ocampo Hermida A; Martínez Vilela J; Pérez Rodríguez MT; Gavilán Montenegro MJ; Arenas Villarroel LJ; Miralles Alvarez C; Rodríguez Dasilva A; Martínez Vázquez C
    J Investig Allergol Clin Immunol; 2009; 19(3):250-1. PubMed ID: 19610279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enfuvirtide desensitisation: due to a failed case].
    López-de-Torre Querejazu A; Ibarra Barrueta O; Santos Ibañez A; Mayo Suárez J
    Farm Hosp; 2012; 36(2):112-3. PubMed ID: 22024011
    [No Abstract]   [Full Text] [Related]  

  • 17. Desensitization to hydroxychloroquine: 4 cases.
    Caramaschi P; Barbazza R; Tinazzi I; Biasi D
    J Rheumatol; 2011 Oct; 38(10):2267; author reply 2267. PubMed ID: 21965696
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.
    Gutiérrez F; García L; Padilla S; Alvarez D; Moreno S; Navarro G; Gómez-Sirvent J; Vidal F; Asensi V; Masiá M;
    HIV Med; 2014 Apr; 15(4):213-23. PubMed ID: 24215356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower-dose efavirenz: what is needed before implementation?
    Maartens G; Meintjes G
    Lancet Infect Dis; 2015 Jul; 15(7):749-51. PubMed ID: 25877960
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropsychiatric effects of efavirenz: delayed onset.
    Dawson S; Woods C
    Int J STD AIDS; 2005 Nov; 16(11):769-70. PubMed ID: 16303077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.